Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion May 11, 2004 8:10pm
289 Views
Post# 7472736

RE: Proboscis - GBM

RE: Proboscis - GBMBecause of your posted high regard for Bilo I was even thinking about lightening up yesterday after reading everthing that was wrong with this company in his latest post. Fortunately my son and son-in-law both talked me out of it. If Reolysin flops I won't have a friend left in the world. well, there are a few people who have bought onc on my personal advice, and while they have been much happier lately, i can't say given the progress (or lack thereof) on the business front that i am totally satisfied. as someone observed earlier, this stock is trading on technicals, not on fudamentals/news since there is little news that isn't already anticipated and priced in to the stock. (the only news that isn't priced in is TRIAL RESULTS, imo.) accordingly, without any substantial news on that front expected anytime soon there is little in terms unexpected substantive progress in the near term to drive this stock higher. (and sorry but i don't call announcements that say the UK has approved conducting of ph I systemic reolysin trials or filing of FDA applications as unexpected substantive progress.) What a trading stock. i would guesstimate that at least 3/4 of the daily volume since the 52 week high is attributable to short term traders.
Bullboard Posts